These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17717562)

  • 21. Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: What is next?
    Kalantar-Zadeh K
    Semin Dial; 2005; 18(5):365-9. PubMed ID: 16191172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variability in estimated glomerular filtration rate values is a risk factor in chronic kidney disease progression among patients with diabetes.
    Tseng CL; Lafrance JP; Lu SE; Soroka O; Miller DR; Maney M; Pogach LM
    BMC Nephrol; 2015 Mar; 16():34. PubMed ID: 25885708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of dialysis patients and heart failure patients.
    Kalantar-Zadeh K; Abbott KC; Kronenberg F; Anker SD; Horwich TB; Fonarow GC
    Semin Nephrol; 2006 Mar; 26(2):118-33. PubMed ID: 16530605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular calcification in patients with nondialysis CKD over 3 years.
    Górriz JL; Molina P; Cerverón MJ; Vila R; Bover J; Nieto J; Barril G; Martínez-Castelao A; Fernández E; Escudero V; Piñera C; Adragao T; Navarro-Gonzalez JF; Molinero LM; Castro-Alonso C; Pallardó LM; Jamal SA
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):654-66. PubMed ID: 25770175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrorenal interaction and stroke.
    Toyoda K
    Contrib Nephrol; 2013; 179():1-6. PubMed ID: 23676853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethnic minority disparities in progression and mortality of pre-dialysis chronic kidney disease: a systematic scoping review.
    Hounkpatin HO; Fraser SDS; Honney R; Dreyer G; Brettle A; Roderick PJ
    BMC Nephrol; 2020 Jun; 21(1):217. PubMed ID: 32517714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of stage 1-5 chronic kidney disease in Mainland China.
    Lai X; Zhang AH; Chen SY; He L; Su CY; Fan MH; Wang T
    Ren Fail; 2014 May; 36(4):520-5. PubMed ID: 24456114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk stratification of cardiovascular events in patients at all stages of chronic kidney disease using myocardial perfusion SPECT.
    Yoda S; Nakanishi K; Tano A; Kasamaki Y; Kunimoto S; Matsumoto N; Sato Y; Hirayama A
    J Cardiol; 2012 Nov; 60(5):377-82. PubMed ID: 22890072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions.
    Kalantar-Zadeh K; Kilpatrick RD; McAllister CJ; Greenland S; Kopple JD
    Hypertension; 2005 Apr; 45(4):811-7. PubMed ID: 15699452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kidney Disease Among African Americans: A Population Perspective.
    Laster M; Shen JI; Norris KC
    Am J Kidney Dis; 2018 Nov; 72(5 Suppl 1):S3-S7. PubMed ID: 30343720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A story half untold: adiposity, adipokines and outcomes in dialysis population.
    Kwan BC; Beddhu S
    Semin Dial; 2007; 20(6):493-7. PubMed ID: 17991193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kidney insufficiency and nutrient-based modulation of inflammation.
    Kalantar-Zadeh K; Stenvinkel P; Bross R; Khawar OS; Rammohan M; Colman S; Benner D
    Curr Opin Clin Nutr Metab Care; 2005 Jul; 8(4):388-96. PubMed ID: 15930963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zinc Deficiency: A Potential Hidden Driver of the Detrimental Cycle of Chronic Kidney Disease and Hypertension.
    Ume AC; Wenegieme TY; Adams DN; Adesina SE; Williams CR
    Kidney360; 2023 Mar; 4(3):398-404. PubMed ID: 36996303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Obesity Paradox in Kidney Disease: How to Reconcile it with Obesity Management.
    Kalantar-Zadeh K; Rhee CM; Chou J; Ahmadi SF; Park J; Chen JL; Amin AN
    Kidney Int Rep; 2017 Mar; 2(2):271-281. PubMed ID: 28439569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies to prevent kidney disease and its progression.
    Kalantar-Zadeh K; Li PK
    Nat Rev Nephrol; 2020 Mar; 16(3):129-130. PubMed ID: 32005966
    [No Abstract]   [Full Text] [Related]  

  • 37. Dialysis: Is the road to survival paved with good mineral management?
    Komaba H; Fukagawa M
    Nat Rev Nephrol; 2011 Apr; 7(4):185-6. PubMed ID: 21441966
    [No Abstract]   [Full Text] [Related]  

  • 38. The Role of Ethnic Variation and CKD.
    Harawa NT; Norris KC
    Clin J Am Soc Nephrol; 2015 Oct; 10(10):1708-10. PubMed ID: 26416945
    [No Abstract]   [Full Text] [Related]  

  • 39. Oh! What a tangled web we weave.
    Arora N; Chertow GM
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1066-7. PubMed ID: 23766364
    [No Abstract]   [Full Text] [Related]  

  • 40. Basic description of the dialysis population of Kuwait: The 2015 data.
    AlSahow A; AlYousef A; AlHelal B; AlSharekh M; Marzouq A
    Saudi J Kidney Dis Transpl; 2016; 27(6):1207-1210. PubMed ID: 27900967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.